Use Salix Pharmaceuticals Ltd. story together with your assets to enhance returns of your portfolios as well as to check it against diversification policy that fits your risk preferences.
RTT News - Jan 25, 2012
(RTTNews) - UK-based retailer WH Smith Plc (SMWH.L: News ), Wednesday, in a trading update, said its total sales for the 21 weeks ended January 21, declined 3 percent from last year.
WH Smith hits profit targets despite lower sales - Proactive Investors UK
Story Momentum
This story from www.rttnews.com contributed to next trading day price decline. The story delta to the next closing price was 0.61% . The story delta to the current price is 9.00% .
IT Business Net - May 10, 2012
By GrabNetworks Salix Pharmaceuticals (SLXP) today had its estimates increased by Jefferies (JEF) after the company beat earnings estimates.
Junction Report - May 9, 2012
Salix Pharmaceuticals (NASDAQ: SLXP)'s stock had its ?neutral? rating restated by Zacks in a report issued on Wednesday. They currently have a $55.00 target price on the stock.
Auriga Reiterates Hold on Salix Pharmaceuticals (SLXP) - Movie News Guide (blog)
StreetInsider.com (subscription) - May 8, 2012
Jefferies analysts raised their price target on Salix Pharmaceuticals (NASDAQ: SLXP) from $54.00 to $63.00 while maintaining a BUY rating on the company.
Number of Shares Shorted is total amount of shares that are currently sold short by investors. When stock is sold short, the short seller assumes the responsibility of buying the stock back at a lower price. The speculator will make money if the stock goes down in price or will experience loss if the stock price goes up.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
